Latest filing published 07 May 2015 for Auspex Pharmaceuticals, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Thomas, McNerney & Partners II, LLC is a declared insider of Auspex Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 10 February 2014 to 5 May 2015, the count stands at 12 filings.
Both buying and selling appear: 1 purchase worth €727k, against 1 sale worth €34.1M. Sales outweigh purchases by €33.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 option exercises. So far in 2015, the count stands at no purchases and 1 sale.
Most recently, on 7 May 2015, the filings show a transaction in Auspex Pharmaceuticals, Inc. The last purchase on record was published on 1 October 2014, which is 4,406 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations